Lenz Therapeutics stock rises after FDA approves presbyopia eye drops
Go back to Lenz Therapeutics stock rises after FDA approves presbyopia eye drops| (NASDAQ: LENZ) | Delayed: 3.92 +0.20 (5.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.72 | 52 Week High | $ | |||
| Open | $3.75 | 52 Week Low | $ | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $3.66 | EPS | $ | |||
| Volume | 923,820 | |||||

